Skip to main content
Funded Studies

Peter T. Lansbury, PhD

Chief Scientific Officer at Lysosomal Therapeutics, Inc.

Professor of Neurology at Harvard Medical School

Location: Cambridge, MA United States

Peter T. Lansbury, Jr., PhD, was born in 1958 and grew up in Buffalo, NY. He received his AB (cum laude) in chemistry from Princeton University in 1980 and subsequently received his PhD in organic chemistry from Harvard University in 1985 under the direction of Nobel laureate E. J. Corey. His postdoctoral fellowship was spent at the Rockefeller University, working with the late Tom Kaiser. In 1988, he accepted a position as assistant professor of chemistry at MIT and was promoted to associate professor in 1993.

He moved to his current position at the Center of Neurologic Diseases in 1996 and was promoted to professor of neurology at Harvard Medical School in 2004. During this time, he founded the Laboratory for Drug Discovery in Neurodegeneration and the Morris K. Udall NIH Parkinson’s Disease Research Center of Excellence at Brigham and Women’s Hospital, which he directed for 10 years. He was the founder of Link Medicine, and served as its chief scientific officer from 2005 until its sale to AstraZeneca in 2012.  He is currently chief scientific officer of Lysosomal Therapeutics, Inc., a company focused on developing disease-modifying therapeutics for Parkinson’s and related diseases. 

Associated Grants

  • Cell Assays to Measure Peripheral Response to GCase Activators


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.